The main risk is a timing mismatch between proof, delivery, and valuation. IonQ must demonstrate the 256-
qubit chip system, absorb manufacturing expansion, and convert
backlog and pilots into repeatable production revenue before pricing pressure,
dilution, or multiple compression outruns the underlying business.